Patents Assigned to MRC Holdings Pty Limited
  • Patent number: 6664246
    Abstract: The present invention is concerned with a pharmaceutical composition suitable for the treatment of cancer and in particular with a pharmaceutical composition containing vitamin D or a precursor, analogue or metabolite thereof and the use of these compositions in the treatment of a tumor in a subject.
    Type: Grant
    Filed: May 22, 2001
    Date of Patent: December 16, 2003
    Assignee: MRC Holdings PTY Limited
    Inventor: David Morris
  • Patent number: 6486144
    Abstract: Method for the treatment of tumors in the liver of a subject wherein a pharmaceutically effective amount of at least one vitamin D compound selected from vitamin D, a precursor of vitamin D or a metabolite or analog thereof, is administered to the subject. The method involves regional delivery of the vitamin D compound to the liver, for example by intraarterial infusion to the hepatic artery. Compositions are also provided for use in such treatment.
    Type: Grant
    Filed: January 20, 2000
    Date of Patent: November 26, 2002
    Assignee: MRC Holdings Pty Limited
    Inventor: David Lawson Morris